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How is it diagnosed?
clinical features
Actively consider constipation as a diagnosis in patients 
with learning disability. A focused history from the patient 
or carer regarding bowel habit (including faecal overflow) 
and abdominal pain is required, with careful attention to 
ensuring that the patient understands. We suggest that 
constipation be specifically considered during all learn-
ing disability checks as part of directed enhanced serv-
ices in the United Kingdom.10 Faeces may be palpable 
on abdominal examination, and rectal examination may 
show impacted faeces or rectal complications such as 
fissures or prolapse. 
Investigations
Abdominal radiography, although usually unnecessary in 
the general population, is often confirmatory and can be a 
useful investigation in people with learning disability.7
How is it managed?
Management principles include emptying the bowel 
and maintaining soft, lubricated stools in the long term 
(months, or even years if necessary). A small randomised 
controlled trial in neurologically impaired children 
showed that increasing dietary fibre significantly increases 
stool frequency and reduces painful defecation.11 Effective 
agents include polyethylene glycol (which provides ben-
efit over long periods for chronic constipation, including 
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Chronic constipation is surprisingly common in p eople 
with learning disability. Communication difficulties, the 
vagueness of the symptoms, and the presence of other 
priorities often mean that carers and clinicians miss look-
ing for this problem.1
Why is it missed?
The usual trigger for doctors to consider this diagnosis 
is the specific mention of constipation by the patient, or 
the communicated history of an abdominal symptom. 
Patients with learning disability may be unable to com-
municate these, to either their doctor or carer. In addition 
to more intuitive presentations such as overflow diarrhoea 
or urinary incontinence, pain from constipation may 
present as distress, sleep disturbance, or behavioural 
changes, including self harm.6 According to expert opin-
ion, recognition of constipation in children with disability 
is commonly delayed, with symptoms often present for 
months or years beforehand.7 In a retrospective cohort of 
hospital deaths caused by intestinal obstruction, people 
with learning disability and constipation presented late 
and with minimal signs and symptoms.8
Why does it matter?
In patients who are less able to indicate the site of pain, or 
perhaps the very existence of pain, it is important to con-
sider this very treatable cause of unnecessary suffering. 
Chronic constipation is also associated with urinary and 
faecal incontinence (further increasing the risk of social 
stigma), chronic nausea, rectal prolapse, anal fissures, 
haemorrhoids, the need for manual evacuation, and hos-
pital admission for faecal impaction.3
When people with learning disability were asked to 
rate their health problems, those listing constipation 
were more likely to have their health rated as poor.9 Learn-
ing disability predicted fatal intestinal obstruction, and 
chronic constipation was a risk factor for this in one hos-
pital based study.8
Case scenario
A 48 year old woman with mild intellectual impairment 
and epilepsy (for which she takes phenytoin) presented 
with left sided abdominal pain. She had mentioned this 
before but had denied constipation or diarrhoea. We 
found an archived radiograph showing moderate faecal 
loading. When pressed, she admitted not knowing what 
“constipation” meant and, in fact, had been manually 
evacuating but was too ashamed to tell anyone.
How common is it?
In a randomly selected institutionalised adult population 
of 215 people with learning disability (IQ <50), 149 cases 
(69.3%) had constipation2 
In children with severe disabilities, estimates of the 
prevalence of constipation vary from 26% to more than 50%3 
People with learning disability are more likely to be taking 
drugs that are associated with constipation, such as 
anticonvulsants, benzodiazepines,2 and antipsychotics 
Other factors associated with constipation in people with 
learning disability include reduced physical mobility and 
refusal to eat2 
Some causes of learning disability, whether inherited (such 
as Down’s syndrome) or acquired (such as cerebral palsy), 
are strongly associated with constipation. In one study, 
74% of children at a cerebral palsy outpatients clinic had 
chronic constipation.4 In comparison, a Canadian study 
of the general adult population showed a prevalence of 
around 15%5
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faecal impaction),12 psyllium, and lactulose (on the basis 
of a systematic review of 20 commonly used agents).13 Rec-
tal suppositories or enemas are necessary only occasion-
ally and should be considered a last resort in children.14 
Three before and after studies recommend regular toileting 
and behavioural treatments including rectal sensory bio-
feedback during defecation and psychological support,12 
which may be especially important in people with learning 
disability. If available, health promotional materials with 
pictures and simple language are particularly helpful for 
those with learning disability.15
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Key POInTs
People with learning disability are prone to constipation, often because of medication, •	
reduced mobility, or refusal to eat
They may not communicate the typical symptoms to doctors and carers and sometimes •	
present with apparently unrelated behavioural change; untreated constipation may cause 
unnecessary problems and occasionally even death
Doctors should actively consider and exclude the diagnosis of constipation in people •	
with learning disability using history, abdominal examination, and, where necessary, 
abdominal radiography
Although ideally treatment should include increasing dietary fibre, laxatives are usually •	
needed, sometimes for long periods
a Patient’s Journey
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Karen Low helps Teresa Harding tell the story 
of her life with dopa responsive dystonia, 
which was not diagnosed until she was in her 
mid twenties
I was six when they sent me to the children’s hospital. The 
doctor told my mother, “I don’t know why you’ve brought 
this child here—you’re doing it for attention and you’ve 
wasted my time.” My mother says that if they had watched 
me walk out to the car they would have seen the problem, 
but they just thought I was attention seeking. In my old 
notes it says that I had a psychological problem.
My legs continued to deteriorate. I struggled to walk and 
sometimes collapsed in the street. I would gradually become 
worse as the day went on and my father often had to carry me. 
This continued until I was nine when my parents arranged a 
private appointment with a neurologist. They felt this was the 
only way to make someone see what was happening.
The consultant admitted me to Frenchay Hospital, B ristol, 
for observation. The floors were very slippery so I found it 
very difficult to walk and my feet pulled inward. Initially, my 
parents were told I had muscular dystrophy; but then the 
doctors decided that this was the wrong diagnosis because 
my muscles were not wasting away. I remained under the 
care of the neurologist for the next nine years, during which 
time I had five years of physiotherapy that caused my legs to 
become weaker, rather than stronger. Various tests, includ-
ing a brain scan, found nothing wrong. I had iron callipers 
on both legs, and then I progressed to plastic splints. My pos-
ture became very poor and I continued to struggle to walk. 
On every annual visit I was told I was “unique” and that they 
did not know what was wrong with me.
At 18 I had a kidney infection and could not stop vomit-
ing, so my GP gave me antibiotics and an anti-sickness injec-
tion. Things immediately went from bad to worse. For several 
hours my ankles pulled inwards, my whole body went stiff, 
and I was unable to relax. My doctor did not understand 
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what had happened. I had no strength in my legs at all, was 
reduced to crawling, and had lost my sense of balance. I was 
off sick from work as a telephonist for six months and went 
from 161 lbs to 108 lbs. When I saw the neurologist for my 
annual appointment he said, “Whatever happened to you?” I 
told him, but nobody could explain my illness and there was 
nothing more he could do for me. My condition still baffled 
medical staff and that year they wrote me off.
living with my disability
I am quite an outgoing person and I had brilliant friends 
throughout school who really helped me. I have never let 
my illness get to me and nobody has been nasty about 
it, but I did suffer because I couldn’t do the same activi-
ties as everyone else. I could never go on school trips or 
to school camp, because in those days facilities to help 
disabled people did not exist.
So I lived with it—dragging my feet and not being able 
to walk without holding on to something or somebody 
for support. Most of the time I was forced to use a wheel-
chair.
In 1990 I moved to Clevedon with my future husband 
and had my first son. I had been told I would be unable to 
conceive, so it was a shock when I became pregnant. I love 
being a mum, but my disability made it difficult to begin 
with. Social services provided me with home help five days 
a week to assist me with the baby and housework.
My lowest point was after I had had my first son. I had 
gone over on my ankle many times. It was so painful and 
weak that I couldn’t look after my son properly, so I went 
to my GP. 
I was sent back to Frenchay Hospital and saw a doctor 
who asked about my legs rather than my ankle injury, 
which was difficult to understand. He wanted to know 
how far I could walk and how things were during the 
The form of dopa responsive dystonia described here is 
inherited as an autosomal dominant trait and is caused by 
mutations in a gene for guanosine-5-triphosphate (GTP) 
cyclohydrolase (GCH1). This enzyme is essential for normal 
dopamine synthesis. The symptoms and signs of dopa 
responsive dystonia are varied, but onset of dystonia in early 
childhood with marked variation in symptoms throughout 
the day is typical. For this reason, there might be a mismatch 
between the child’s symptoms and the signs that are evident 
to a doctor at a particular time. A range of other neurological 
symptoms and signs have been described in this condition 
including tremor, spasticity, and ataxia. Many people with 
dopa responsive dystonia are misdiagnosed with other 
neurological conditions, but the diagnosis can be confirmed 
in several ways, including DNA analysis. Dopa responsive 
dystonia is often completely curable with levodopa (L-dopa) 
replacement. Some patients respond quickly to a low dose of 
L-dopa, whereas others need a larger dose and respond more 
slowly. 
Cerebral palsy describes a group of permanent disorders of 
the development of movement and posture, causing activity 
limitation, that are attributed to non progressive disturbances 
that occurred in the developing fetal or infant brain. Not all 
conditions that affect posture and movement and start in 
early childhood are a type of cerebral palsy. The prevalence 
of cerebral palsy varies throughout the world but is about 2 
in 1000 live births in developed countries. The prevalence of 
DRD is unknown, but is a much rarer condition. In 14 years as 
a consultant paediatric neurologist I have diagnosed five new 
cases. There are likely to be many undiagnosed patients in 
the UK.
Magnetic resonance brain imaging is crucial in evaluating 
the cause of a patient’s cerebral palsy. Although normal brain 
imaging does occur in some people with cerebral palsy, this 
raises the possibility of an alternative diagnosis. The condition 
starts in early childhood and does not fluctuate markedly as 
the day goes by. Although the functional abilities of a child 
with CP might change over the years—for instance losing 
the ability to walk independently in adult life—a marked 
progression in symptoms should raise the possibility of an 
alternative diagnosis. Cerebral palsy does not usually recur 
within families. A first degree relative with cerebral palsy 
should certainly lead to the diagnosis being questioned. 
A growing list of rare genetic and metabolic disorders, 
can masquerade as cerebral palsy. Accurate diagnosis is 
important because some of these conditions are treatable—or 
even curable—and some might recur in families.
No doctor can be omniscient. There will always be patients 
with rare conditions that the doctor is not familiar with. 
Keeping an open mind about potential diagnoses and 
listening carefully to the patient’s story is important.
Philip Jardine
LessOns TO Be LeARnT
The bad
I felt quite let down by the medical profession in my younger 
years. It felt like no one listened to my parents, really looked at 
me, or understood the gravity of the situation.
Having my symptoms labelled as “psychological” is still 
particularly upsetting.
In my younger years I was unable to participate in many 
activities that other people my age could do and sometimes 
felt excluded. Nowadays disabled facilities are so much 
better and allow for people with disabilities to be much more 
included.
The good
I have now met doctors who believe in listening to mothers’ 
instincts and paying attention to what the patient is telling 
them. This would be my advice for doctors reading this—
always listen to what the patient is telling you.
One of the most important things was that someone could give 
my problem a name and could then do something to treat it.
I have now met doctors who believe in excellent 
communication. My current specialist is so accessible, he 
listens to all my concerns and doesn’t even mind if I contact 
him occasionally with email queries, and he always gets back 
to me very quickly.
I hope that I can help other people who have this condition. I 
have become actively involved with the Dystonia Society and 
speaking to families who are newly diagnosed.
day and the evening. When I asked him the reasons for 
these questions, he said “If we can get you on the right 
medication, it can change your life.”
the turning point
How right he was. I was told that I had a condition called 
dopa responsive dystonia. I was started on co-beneldopa 
125 mg, one daily for the first week, increasing to six daily 
A DOCTOR’s PeRsPeCTIve
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within six weeks. After taking the first tablet I noticed an 
instant effect. I felt as though I had strength in my legs for the 
first time in years. I then stabilised at two tablets daily and 
continued to improve slowly over the next months. Gradu-
ally my balance and posture improved and my body began to 
relax. In April 1992 I realised my dream of walking down the 
aisle, with my splints still in place under my wedding dress. 
On our honeymoon I discarded my splints and started the dif-
ficult process of teaching myself to walk again.
My second son was born in April 1994. During my preg-
nancy my consultant advised that I reduce my medication, 
which I did without complications. I increased the dose 
again after the birth.
I am now 45 years old—I walk normally and have a very 
active family life. My great love is line dancing. I was always 
afraid of the illness returning and I’ve had a few blips that 
really worried me. I asked the consultant if I would get used 
to the tablets and whether the condition would come back. 
He reassured me that should that ever happen; I can just 
have my medication increased.
I still class myself as disabled—I still have the condition 
and if I don’t take the medication I can’t walk. On some occa-
sions when dancing I have suddenly thought I had better sit 
down or I would fall over.
Since my diagnosis other family members have been 
tested. Now we know that my mother, my eldest son, both 
my aunts, and some of their children have the condition. 
They are all being treated for it. If Dr Jardine hadn’t put in the 
effort to investigate my family they would never have known 
that they have dopa responsive dystonia as well.
I continue to take co-beneldopa and will for the rest of 
my life. It is a small price to pay for the life I thought I would 
never have.
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ADDITIOnAL ResOURCes
The Dystonia Society (www.dystonia.org.uk)—A UK wide 
charity providing support, advice, and information for anyone 
affected by dystonia
Action for Dystonia, Diagnosis, Education & Research (ADDER) 
(www.actionfordystonis.co.uk)— 
UK based group aiming to advance education, promote 
treatment, and offer support for patients
Contact a Family (www.cafamily.org.uk/Direct/d51.
html)—Dystonia page of Contact a Family, the UK site that 
allows users to contact other families in similar positions. 
Specifically aimed at families with disabled children
Dystonia Support 4 U (www.dystonia-support4u.com/about.
php)—UK based support group
The European Dystonia Federation (www.dystonia-europe.
org)—This portal includes links to websites about dystonia in 
different European countries
Dystonia Bulletin Board (www.dystonia-bb.org/forums/
asd/)—Sponsored by the Dystonia Medical Research 
Foundation, provides support and discussion for patients, 
family members, and caregivers with all forms of dystonia
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A healthy, non-smoking 54 year old woman consults with 
a severe acute cough. It started two weeks ago with symp-
toms of a common cold, but she is worried about its dura-
tion and would like something to “clear it up.”
What you should cover
• Ask about the duration and nature of cough, 
dyspnoea, wheezing, thoracic pain, upper respiratory 
tract symptoms, smoking, and use of drugs. Explore 
restrictions in activities as a result of the cough.
• Are the symptoms caused by a self limiting or serious 
illness? Acute cough (less than three weeks) is most 
commonly caused by self limiting infections of the 
respiratory tract. Consider other common causes: 
(passive) smoking, bronchial hyper-reactivity, use of 
angiotensin converting enzyme inhibitors, postnasal 
drip, and gastro-oesophageal reflux disease (unlikely 
with no history of heartburn or regurgitation).
• Consider pneumonia—factors associated 
with an increased risk include use of oral 
glucocorticosteroids, heart failure, chronic 
obstructive pulmonary disease (COPD), insulin 
dependent diabetes, serious neurological disorder, 
rheumatoid arthritis, Parkinson’s disease, cancer, and 
older age (especially over 80).
• Asthma must be considered but is unlikely with 
no history of respiratory or atopic problems. 
COPD should be considered in smokers. Persisting 
paroxysms of cough, sometimes with vomiting, 
suggest whooping cough. Assess for less common 
causes, including Q fever, pulmonary embolism, 
tuberculosis, heart failure, and malignancy.
What you should do
Physical examination and additional diagnostic testing
Gauge degree of illness by assessing fever, tachypnoea, 
tachycardia, and level of consciousness. CRB-65 scoring 
(new onset mental confusion, respiratory rate >30/min, 
blood pressure: systolic <90 mm Hg or diastolic <60 mm 
Hg, age ≥65) may be useful.
Examine the pharynx for signs of upper respiratory tract 
infection; perform lung auscultation and percussion. How-
ever, clinical signs and symptoms do not reliably differenti-
ate atypical from typical pneumonia.
For suspected lower respiratory tract infection, near 
patient measurement of C reactive protein (CRP) can help 
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differentiate serious disease from self limiting disease and 
has more diagnostic value than erythrocyte sedimentation 
rate and leucocyte count. A low C reactive protein (<20 
mg/l) rules out pneumonia and can help in withholding 
antibiotics.
Microbiological tests are not routinely recommended in 
primary care. Chest radiography should be performed if seri-
ous illness (malignancy, heart failure) is suspected, although 
it has a limited role in primary care for detecting pneumonia 
on logistical and economic grounds.
If whooping cough is suspected and the patient lives close 
to a newborn infant or pregnant woman, antipertussis toxin 
IgG antibodies should be measured (single raised titre is 99% 
specific for diagnosis).
advice and treatment
Patients often worry about coughs and expect anti biotics. 
Eliciting their main concerns and expectations, and their 
view on antibiotics, ensures the patient’s agenda is dealt with 
and “opens up” the conversation about a nti biotics.
A symptomatic and prognostic diagnosis is better than an 
aetiological or anatomical one, because aetiology in acute 
cough is often not known. Discuss the association between 
smoking and symptoms, and consider a smoking interven-
tion (see NICE guidance).
Dextromethorphan is an effective antitussive that sup-
presses cough reflex (number needed to treat (NNT) 3-8). 
Codeine has no greater efficacy but more side effects. Encour-
age self management strategies including rest, analgesics, 
antipyretics, and regular fluids. Home remedies such as 
lemon and honey may alleviate symptoms. Patients report 
some effect of expectorants, mucolytics, antihistamines (or 
decongestants), and inhaled bronchodilators, but little evi-
dence supports or discourages their use. Potential benefits 
must be weighed against the risk of side effects. Antibiotics 
are not indicated in cough caused by upper respiratory tract 
infection and offer limited benefit in terms of cough resolution 
(NNT 6) in acute bronchitis. Potential benefits (improvement 
in mean duration of cough of less than one day) and adverse 
effects (nausea, diarrhoea, rash) must be balanced. Antibiot-
ics are likely to be beneficial for community acquired pneu-
monia or lower respiratory tract infection with a potentially 
complicated course—follow local guidelines on first choice 
of agent. British Thoracic Society guidelines for community 
acquired pneumonia recommend amoxicillin 500 mg three 
times daily for seven days or, in case of penicillin hypersen-
sitivity, doxycycline or clarithromycin. In whooping cough, 
treatment may not affect the patient’s symptoms, but a seven 
day course of erythromycin within 21 days of onset reduces 
the period of infectivity and may prevent transmission.
Consider hospital referral for patients who have lower 
respiratory tract infection with signs of severe illness, age 
over 80, comorbidity, or suspected pulmonary embolism or 
malignancy. CRB-65 scoring can help determine se verity.
Create a safety net by discussing factors that should 
prompt reconsultation (such as haemoptysis, fever lasting 
more than four days, increasing dyspnoea and fast breath-
ing, decreasing consciousness, and confusion) and back up 
your advice with an information leaflet (box).
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ReCOmmenDeD ResOURCes FOR PATIenTs
European Centre for Disease Control (www.antibiotic.ecdc.
europa.eu)—Patient information brochure on acute cough, 
colds, and flu 
European Centre for Disease Prevention and Control 
(http://ecdc.europa.eu/en/eaad/antibiotics/Pages/
messagesForPublic.aspx)—Advice on using antibiotics 
responsibly
NHS Direct (www.cks.nhs.uk/patient_information_leaflet/
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chest infection
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PICTURE QUIZ more than skin deep?
1  The different types of melanoma are superficial spreading melanoma, lentigo maligna, acral lentiginous 
melanoma, and nodular melanoma.
2  Breslow’s thickness measures in millimetres the distance between the upper layer, or granulous layer, of the 
epidermis and the deepest point of the tumour’s penetration, allowing staging of malignant melanomas. The 
thinner the Breslow’s thickness, the better the chance of a cure.
3  The computed tomography and radiograph images show multiple polypoid filling defects in the proximal jejunum.
4  The investigation of choice to facilitate histological evaluation is small bowel enteroscopy and biopsy.
5  The most likely diagnosis is superficial spreading metastatic malignant melanoma.
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